In gefitinib-resistant epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), lactate is overproduced by the upregulation of GLUT1, HK2, and LDHA [35]. Here, SLC2A1 is linked to non-small cell lung carcinoma.